Cambridge Investment Research Advisors’s Cambria Cannabis ETF TOKE Stock Holding History

Cambridge Investment Research Advisors’s Portfolio TOKE Stock Details TOKE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-12,319	Closed	-$63K	–	4184
2026 Q1	$63K	Sell	12,319 -1,000	-8%	-$5.72K	﹤0.01%	3836
2025 Q4	$82K	Buy	+13,319	New	+$79K	﹤0.01%	3720

Cambridge Investment Research Advisors's TOKE Position: Q2 2026 in Review

Cambridge Investment Research Advisors sold out of Cambria Cannabis ETF (TOKE) in Q2 2026, closing a stake of 12,319 shares — an estimated $63K sold.

Cambridge Investment Research Advisors first reported a position in TOKE in Q4 2025 and held it in 2 quarters. The position peaked at $82K in Q4 2025. 0 funds tracked by Wall St. Rank hold TOKE as of Q2 2026.

Cambridge Investment Research Advisors reported no remaining Cambria Cannabis ETF position as of Q2 2026 after selling out during the quarter.
Cambridge Investment Research Advisors sold 12,319 Cambria Cannabis ETF shares in Q2 2026, an estimated $63K.
Cambridge Investment Research Advisors first reported a position in Cambria Cannabis ETF in Q4 2025 and held it in 2 quarters.
Cambridge Investment Research Advisors's Cambria Cannabis ETF position peaked at $82K in Q4 2025.
0 funds tracked by Wall St. Rank held Cambria Cannabis ETF as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.